4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016046
CBO & EVP sold 1,968 shares at $45.27 ($89,091)
- CBO & EVP returned 3,394 shares (to the company)
- CBO & EVP acquired 24,663 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kassberg Thomas Richard CBO & EVP | 2023-03-01 | Grant or award | +2,663 | 230,222 | D: show line 1 in the form | ||
| Kassberg Thomas Richard CBO & EVP | 2023-03-01 | Grant or award | +22,000 | 252,222 | D: show line 2 in the form | ||
| Kassberg Thomas Richard CBO & EVP | 2023-03-01 | Sale | −1,968 | $45.27 | $89,091 | 250,254 | D: show line 3 in the form |
| Kassberg Thomas Richard CBO & EVP | 2023-03-01 | Returned to the company | −3,394 | $45.65 | $154,936 | 246,860 | D: show line 4 in the form |
| Open-market sales · 1,968 sh · avg $45.27 · $89,091 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kassberg Thomas Richard CBO & EVP | 2023-03-01 | Grant or award · Stock Option (Right to Buy) | +39,400 | 39,400 | D: show line 5 in the form |
Loading xslF345X03/doc4.xml…